How do you counsel women on anti-CD20 therapy for MS who are planning for pregnancy?

I counsel patients that anti-CD20 therapies are relatively safe in patients with MS who are considering pregnancy. Monoclonal antibodies are not transported across the placenta until the 2nd trimester, and with a half-life of 20-30 days (depending on which anti-CD 20 is used), the amount that crosse...